Biotech

All Articles

Viridian eye disease stage 3 hits, accelerating push to rivalrous Amgen

.Viridian Therapeutics' stage 3 thyroid eye ailment (TED) medical test has reached its primary and a...

Bain unveils $3B fund for life scientific research providers

.Along with a powerful performance history for identifying rough diamonds, Bain Funding Life Science...

Genentech's cancer restructure made 'for medical explanations'

.The latest selection to combine Genentech's 2 cancer cells divisions was actually created "clinical...

Tern oral GLP-1 reveals 5% fat loss at 1 month at greatest dose

.Terns Pharmaceuticals' decision to fall its liver ailment aspirations may however pay, after the bi...

Merck, Daiichi regular early results in tiny mobile bronchi cancer cells with updated ADC records

.Merck &amp Co.'s long-running effort to land a hit on tiny cell bronchi cancer (SCLC) has acquired ...

Boehringer, Bayer advancement lung cancer cells drugs toward Astra war

.Some individuals along with non-small cell bronchi cancer (NSCLC) possess mutations in a genetics c...

MBX aims for $136M IPO to take rival to Ascendis right into phase 3

.MBX has fleshed out programs to absorb over $136 million coming from its own IPO as the biotech see...

Relay breast cancer data tee up clash with AstraZeneca's Truqap

.Relay Rehabs has beaten its own survival goal in a first-in-human bust cancer cells research study,...

AZ summarizes AI-enabled TROP2 biomarker tactic for Daiichi ADC

.AstraZeneca has utilized artificial intelligence to create an unique biomarker for its own Daiichi ...

AstraZeneca IL-33 drug falls short to enhance COPD breathing in ph. 2

.AstraZeneca execs state they are "not worried" that the failing of tozorakimab in a stage 2 severe ...